Literature DB >> 8130287

Is group physical therapy superior to individualized therapy in ankylosing spondylitis? A randomized controlled trial.

A Hidding, S van der Linden, M Boers, X Gielen, L de Witte, A Kester, B Dijkmans, D Moolenburgh.   

Abstract

PURPOSE: To study the effects of adding supervised group physical therapy to unsupervised individualized therapy in ankylosing spondylitis.
METHODS: One hundred forty-four patients were randomized to exercises at home, or the same plus weekly group physical therapy for 9 months. Endpoints were spinal mobility, fitness (maximum work capacity by ergometry), functioning (Sickness Impact Profile, Health Assessment Questionnaire for the Spondylarthropathies, and Functional Index), and patient's global assessment of change on a 10-cm visual analogue scale.
RESULTS: Thoracolumbar flexion and extension increased by an average of 0.5 cm (9%) after home exercises, and by 0.9 cm (16%) after group therapy. Maximum load in ergometry decreased by 2 W (1%) after home exercises, but increased by 7 W (4%) after group therapy. Global assessment improved by 0.3 (6%) after home exercises, and by 1.7 (34%) after group therapy. These three differences were statistically significant. There were no significant differences in chest expansion, cervical rotation, or the self-assessments of functioning.
CONCLUSIONS: Group physical therapy proved superior to individualized therapy in improving thoracolumbar mobility and fitness, and had an important effect on global health reported by the patients.

Entities:  

Mesh:

Year:  1993        PMID: 8130287     DOI: 10.1002/art.1790060303

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  24 in total

Review 1.  Spondylarthropathies: options for combination therapy.

Authors:  A M van Tubergen; R B Landewé; S van der Linden
Journal:  Springer Semin Immunopathol       Date:  2001

2.  [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].

Authors:  J Braun; J Zochling; E Märker-Hermann; G Stucki; H Böhm; M Rudwaleit; H Zeidler; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 3.  Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; M Dougados; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

Review 4.  Health related quality of life outcome instruments.

Authors:  Gunnar Németh
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

5.  Effect of Pilates training on people with ankylosing spondylitis.

Authors:  L Altan; N Korkmaz; M Dizdar; M Yurtkuran
Journal:  Rheumatol Int       Date:  2011-04-17       Impact factor: 2.631

6.  On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis.

Authors:  M M Murawski; P A Miederhoff
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

7.  Comparison of group-based exercise versus home-based exercise in patients with ankylosing spondylitis: effects on Bath Ankylosing Spondylitis Indices, quality of life and depression.

Authors:  Hale Karapolat; Yeşim Akkoc; Ismail Sari; Sibel Eyigor; Servet Akar; Yeşim Kirazli; Nurullah Akkoc
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

8.  Factors related to change in global health after group physical therapy in ankylosing spondylitis.

Authors:  A Hidding; S van der Linden
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

Review 9.  Exercise therapy for spondyloarthritis: a systematic review.

Authors:  Tom O'Dwyer; Finbar O'Shea; Fiona Wilson
Journal:  Rheumatol Int       Date:  2014-02-19       Impact factor: 2.631

10.  Stanger bath therapy for ankylosing spondylitis: illusion or reality?

Authors:  Eda Gurcay; Serdil Yuzer; Emel Eksioglu; Ajda Bal; Aytul Cakci
Journal:  Clin Rheumatol       Date:  2008-03-21       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.